MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    IgG to neurotensin in blood of Parkinson’s disease patients

    Z. Muruzheva, M. Absalyamova (Saint-Petersburg, Russian Federation)

    Objective: The aim of the study was measurement of IgG to NT in blood plasma of Parkinson's disease patients. Background: Neurotensin (NT) is a 13-amino-acid…
  • 2022 International Congress

    Gait declines faster over time in people with Parkinson’s disease converting to a freezing of gait phenotype

    T. Virmani, A. Glover, L. Pillai (Little Rock, USA)

    Objective: To monitor gait progression in people with Parkinson’s disease (PwPD) who convert from a non-freezing (noFOG) to a freezing of gait (FOG) phenotype. Background:…
  • 2022 International Congress

    Perceive: A data extraction and analysis toolbox for brain signals from sensing enabled deep brain stimulators

    WJ. Neumann (Berlin, Germany)

    Objective: Develop an open source toolbox that facilitates data extraction, analysis, artifact correction and standardization for the DBS research community. Background: Novel sensing enabled implantable…
  • 2022 International Congress

    Sleep Disorders in Normotensive Hydrocephalus

    S. Regalbuto, M. Terzaghi, M. Todisco, R. Zangaglia, F. Valentino, C. Pacchetti (Pavia, Italy)

    Objective: Objective of the work was to study the prevalence of sleep disorders, Rem Sleep Behaviour Disorder (RBD) and obstructive sleep apnea (OSA) in patients with NPH.…
  • 2022 International Congress

    EEG power-spectra parametrization and cognitive ability in Parkinson’s disease

    R. Shoorangiz, N. Slater, G. Hall-Mcmaster, E. Peterson, L. Livingston, S. Grenfell, K. Clifford, A. Harris, I. Kirk, L. Tippett, R. Jones, T. Anderson, T. Melzer, J. Dalrymple-Alford (Christchurch, New Zealand)

    Objective: To parametrize EEG power-spectra and examine the association of periodic and aperiodic components with cognitive ability in Parkinson's disease (PD). Background: PD is associated…
  • 2022 International Congress

    Gold and silver nanoparticle-based Localized Surface Plasmon Resonance Sensor (LSPR) for the detection of histidine as a potential biomarker in Parkinson’s Disease.

    E. Robles, C. Acevedo-Castillo, D. Martínez-Ramírez (Monterrey, Mexico)

    Objective: Previous literature has proven that histamine has a crucial role in the process of neuroinflammation in Parkinson's Disease (PD) . We can indirectly detect…
  • 2022 International Congress

    Insights from skin biopsies: α-synuclein real-time quaking-induced conversion (RT-QuIC) in patients with Parkinson’s disease and multiple system atrophy

    C. Panzer, J. Volkmann, C. Sommer, K. Doppler, A. Kuzkina (Würzburg, Germany)

    Objective: To characterize skin alpha-synuclein (α-syn) pathology in synucleinopathies as a potential tool for differential diagnosis. Background: Differential diagnosis of PD and MSA represents a…
  • 2022 International Congress

    Hyperkinesia associated with tuberculous meningitis in children: report of 2 cases.

    I. Estrada-Bellmann, E. Villarreal-Garza, C. Torres-González, B. Chávez-Luévanos, A. Cantú-Salinas, S. Castillo-Torres (Monterrey, Mexico)

    Objective: We present two pediatric patients with normal neurodevelopment, and incomplete vaccination schedule due to lack of BCG vaccine, who developed hyperkinesias secondary to tuberculous…
  • 2022 International Congress

    ‘A study of seven patients with Hemimasticatory spasm; barriers to treatment and outcomes of botulinum toxin’

    A. Aundhakar, A. Nanavati, B. Mishal, P. Wadia (Mumbai, India)

    Objective: To assess barriers to treatment and outcomes of botulinum toxin in patients treated for Hemimasticatory spasm Background: Hemimasticatory spasm (HMS) is a rare peripherally induced…
  • 2022 International Congress

    Correlation between H-ABC and thyroid hormones signaling in the process of adult neurogenesis

    A. Lopez-Juarez, V. Hernandez, D. Carmona (Leon, Mexico)

    Objective: To analyze a possible correlation between the TH signaling and cellular fate of adult neural stem cells on taiep rats. Background: H-ABC is a…
  • « Previous Page
  • 1
  • …
  • 122
  • 123
  • 124
  • 125
  • 126
  • …
  • 153
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Welcome to the MDS Abstracts Site
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley